Northway Biotech has officially inaugurated a state-of-the-art €61 million cell therapy contract development and manufacturing organization (CDMO) facility in Lithuania, marking a significant expansion in the region’s biopharmaceutical manufacturing landscape. The new site is set to enhance the company’s capacity to support advanced cell therapy development and commercial production, addressing the growing global demand for innovative regenerative medicines. This strategic investment underscores Lithuania’s emerging role as a key hub for cutting-edge biomanufacturing in Europe.
Northway Biotech Launches State-of-the-Art Cell Therapy CDMO Facility in Lithuania
Northway Biotech has officially inaugurated its cutting-edge CDMO (Contract Development and Manufacturing Organization) facility dedicated to cell therapy manufacturing in Lithuania, marking a €61 million investment into the region’s biopharmaceutical landscape. This new site is strategically designed…
—-
Author : EURO-NEWS
Publish date : 2026-09-09 03:56:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
